Transcept announces layoffs

Share this article:

Transcept Pharmaceuticals—known for its sleep drug Intermezzo—is cutting 43% of its workforce.

The company announced Tuesday that six employees will be laid off between now and early 2014, leaving a staff of eight.

The layoffs are part of a larger restructuring that includes reorganizing its board of directors.

The company's lead pipeline product, TO-2070, is for acute migraines.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.